Next Article in Journal
Burnout in Nurses of an Intensive Care Unit during COVID-19: A Pilot Study in Portugal
Next Article in Special Issue
Enhancing Psychological Resilience: Examining the Impact of Managerial Support on Mental Health Outcomes for Saudi Ambulance Personnel
Previous Article in Journal
The Roles of Trust and Its Antecedent Variables in Healthcare Consumers’ Acceptance of Online Medical Consultation during the COVID-19 Pandemic in China
Previous Article in Special Issue
Reducing Violence in Riyadh’s Emergency Departments: The Critical Role of Healthcare Providers
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Factors Affecting the Public Intention to Repeat the COVID-19 Vaccination: Implications for Vaccine Communication

1
Department of Public Health, Graduate School of Public Health, Seoul National University, Seoul 08826, Republic of Korea
2
Gyeonggi Infectious Disease Control Center, Suwon 16508, Republic of Korea
*
Author to whom correspondence should be addressed.
Healthcare 2023, 11(9), 1235; https://doi.org/10.3390/healthcare11091235
Submission received: 21 March 2023 / Revised: 18 April 2023 / Accepted: 21 April 2023 / Published: 26 April 2023

Abstract

:
Although most of the pandemic-related mandatory restrictions have been lifted or eased, vaccination is still recommended as an effective measure to minimize the damage from COVID-19 infection. Since COVID-19 eradication is unlikely, it is necessary to understand the factors affecting the public’s vaccination intention when COVID-19 vaccination is continuously recommended. This study aims to explore the factors that affect the intention to repeat the COVID-19 vaccination in South Korea. An online survey was conducted in January 2022 with adults living in Gyeonggi-do, South Korea. In a hierarchical logistic regression analysis, sociodemographic factors, COVID-19 infection-related factors, COVID-19 vaccination-related factors, sociocultural factors, and communication factors were taken into account. In this study, more than three-quarters (78.1%) of Koreans were willing to repeat the COVID-19 vaccination. People who had high-risk perceptions, had been vaccinated against COVID-19 at least once, had more authoritarian attitudes, regarded the vaccination as a social responsibility, and had positive attitudes toward health authorities’ regular briefings were more likely to repeat the vaccination. In contrast, those who directly or indirectly experienced COVID-19 vaccine side effects and who showed psychological reactance against the government’s vaccination recommendation were less likely to repeat the vaccination. Our research indicates that empathetic communication, promotion of the prosocial aspect of vaccination, and regular and transparent provision of vaccine information are essential for promoting the intention to repeat the COVID-19 vaccination.

1. Introduction

The coronavirus disease 2019 (COVID-19) has tremendously affected people’s lives and livelihoods since the first case was reported in December 2019. As of 17 February 2023, more than 750 million people worldwide have been infected with the disease, including 6.84 million deaths [1]. Even though nonpharmaceutical interventions were effective in limiting the spread of the disease, they entailed societal costs, including economic burden and health problems [2]. Vaccines were seen as essential to getting back to ‘normal’. Pharmaceutical companies, such as AstraZeneca, Moderna, and Pfizer-BioNTech, jumped into the development of vaccines, and COVID-19 vaccines were developed at unprecedented speeds [3]. In a survey of 15 countries conducted in January 2021, 11 of 15 countries showed high levels of intent (more than 65% of respondents agreed to get vaccinated) to take a COVID-19 vaccine, even though there were concerns about the vaccine adverse events and the pace of the clinical trials [4]. Research conducted prior to the Omicron wave revealed that factors, such as demographic factors, beliefs on infection and vaccination, health literacy and governments’ policies (e.g., vaccine approval, vaccination mandate policies, and free vaccination program), influenced COVID-19 vaccination intention and inoculation [5,6,7,8,9]. As of February 2023, over 5.54 billion people worldwide have received at least one dose of a COVID-19 vaccine, and vaccination has played a role in preventing COVID-19-related hospitalization and death [10,11].
The severity of COVID-19 declined with the emergence of the Omicron variant and hybrid immunity, which is acquired from both prior SARS-CoV-2 infection and vaccination [12,13]. Many countries, including South Korea, scrapped or eased COVID-19 restrictions like mask-wearing and physical distancing in 2022, believing the coronavirus was no longer as fatal as it used to be [14]. However, the COVID-19 pandemic is not over, and public health experts recommend getting COVID-19 vaccines every year, similar to the annual flu shot [10,15]. As the positive outcomes of vaccination are expected only when individuals are willing to repeat the immunization, maintaining a high vaccination intention remains a public health challenge. In a survey of 23 countries, for instance, COVID-19 vaccine hesitancy increased between 2021 and 2022 in eight countries, including the United Kingdom, Mexico, and South Africa (ranging from 1.0% to 21.1%) [16]. In the same study, from 1.1% to 28.9% of those who had been vaccinated were hesitant to receive booster vaccines (on average 12.1%) [16].
The vaccination decision-making process is complex and multifaceted; factors at different levels, from the micro (e.g., knowledge, risk perception, and attitude) to the macro (e.g., public policy and trust in government and health authorities) levels, are interrelated and affect the decision-making process [17,18]. Joshi et al. [19] suggested a conceptual framework of factors influencing vaccination decisions and categorized the factors into four groups: (1) sociodemographic factors, (2) COVID-19 infection-related factors, (3) COVID-19 vaccine-related factors, and (4) communication factors. In addition to these four categories, sociocultural factors, such as religious and cultural norms, and social trust are known to influence vaccination decision-making [20,21]. However, most studies exploring the factors predicting intention to receive COVID-19 booster shots have focused on sociodemographic factors and investigated individuals’ willingness to receive a single booster shot [22]. In this study, sociocultural factors were added to the four main factors presented by Joshi et al. [19] to investigate the factors that affect the intention to repeat the COVID-19 vaccination and to suggest communication strategies for a sustainable COVID-19 vaccination program (Figure 1).

2. Methods

2.1. Participants and Procedures

We conducted an online survey from 18 January to 26 January 2022. This is when the Omicron, which is more transmissible than the original SARS-CoV-2 virus and the Delta variant, became the dominant variant, increasing the number of daily new cases in Korea [23]. The Korean government adopted a vaccine pass with an expiration date of 6 months, and people were required to get a booster shot due to the validity period [24]. The participants, adults aged 18 years and over living in Gyeonggi-do, were recruited using the survey panel of Hankook Research Company, one of the major research companies in South Korea. Samples were extracted by sex, age, and eight regions in Gyeonggi-do using proportional and quota sampling methods. The survey Uniform Resource Locator (URL) explaining the purpose of the research was sent via text message and email. The study was approved by the Institutional Review Board of Seoul National University (IRB No. 2201/002-008). The survey was completed by a total of 1000 participants, each of whom had previously consented to participate in the study.

2.2. Measures

2.2.1. Dependent Variable

We asked participants whether they would get vaccinated (or receive booster shots for those who had already been vaccinated at least once) against COVID-19. Response options included “definitely not”, “probably not”, “probably would”, “definitely would”, and “unsure”. For the analysis, positive responses (definitely/probably would) were classified as ‘acceptance’, and negative (definitely/probably not) and ‘unsure’ responses were classified as ‘hesitant/unsure’ [25].

2.2.2. Independent Variables

Sociodemographic factors included sex, age, education level, marital status, monthly household income, and health status (chronic disease), referring to previous research [19,22]. We inquired participants if they had any chronic diseases (e.g., high blood pressure, stroke, diabetes) that had been diagnosed or being treated by a doctor over the past year in order to assess their health status, referring to the Korean National Health and Nutrition Examination Survey (KNHANES) [26].
The COVID-19 infection and related factors included risk perception and history of infection. We measured the risk perception of COVID-19 infection with two items: perceived likelihood and perceived severity [27]. Participants were asked to assess the probability of being harmed by the COVID-19 infection (or reinfection) and the extent of harm that such infection (or reinfection) would cause, using a 5-point Likert-type scale (1 = “very unlikely” to 5 = “very likely”, and 1 = “never serious” to 5 = “very serious”, respectively). According to a prior study, the level of risk perception was determined by averaging the two items [28]. For a history of infection, we asked participants if they or anyone close to them (e.g., family, friends, and colleagues) had been infected with COVID-19.
COVID-19 vaccine-related factors included two variables regarding vaccination experiences: COVID-19 vaccination status and experience of vaccine adverse events. Participants were asked to report their vaccination status: “did not take”, “got a first dose”, “completed primary series (two doses with AstraZeneca, Pfizer-BioNTech, and Moderna, or one dose with Janssen)”, and “got a third shot (booster shot)”. We also asked them if they or anyone close to them experienced adverse reactions after receiving the COVID-19 vaccination.
Sociocultural factors included three variables: political ideology, authoritarian attitude, and collective responsibility. Political ideology was measured in a single item (0 liberal–10 conservatives, 11 unsure) and divided into four categories for analysis: ‘liberal (0–3)’, ‘moderate (4–6)’, ‘conservative (7–10)’, and ‘unsure’. Authoritarian attitudes were assessed with three items developed by the authors based on previous studies [29,30,31]. Examples include: “In response to the COVID-19 pandemic, questioning about or disregarding the authority of scientific knowledge and technologies represents a risk”. The degree of agreement with the statements was measured on a 5-point Likert-type scale (1 = “strongly disagree” to 5 = “strongly agree”), and the mean of the three items was calculated. Cronbach’s alpha value of the items was 0.749, indicating an acceptable internal reliability level. A question from the KFF’s poll on the COVID-19 vaccine was used to assess collective responsibility [32]. Respondents were asked to choose the option that best represented their perspective: “Getting vaccinated against COVID-19 is a personal choice to prevent the spread of the coronavirus”, “Getting vaccinated is everyone’s responsibility to protect the health of others”, “Both”, “Neither”, and “Don’t know”.
For communication factors, we measured the attitude toward the regular briefing of health authorities with three items and averaged them [33]. Respondents were asked to rate the reliability and helpfulness of the regular briefings, as well as how much attention they paid to the briefings using a 5-point Likert-type scale (1 = “not at all” to 5 = “very much”). Internal reliability of the three items was good (Cronbach’s alpha = 0.890). Additionally, the psychological reactance against the government’s vaccination recommendation was estimated using five items developed by the authors with reference to a prior study [34]. The examples include “The health authorities seem to force vaccination” and “The health authorities do not seem to fully understand the public’s doubts and concerns about vaccines”. Participants were asked to indicate the extent to which they agreed with the statements using a 7-point Likert-type scale (1 = “strongly disagree” to 7 = “strongly agree”), and the mean of the five items was calculated. Cronbach’s alpha value of the items was 0.956, which indicates an excellent internal reliability level. The ordinal Likert-type scales were treated as continuous scales in bivariate analysis and logistic regression analysis.

2.3. Data Analysis

A descriptive analysis was conducted to provide information on the sociodemographic characteristics of the survey participants. Quantitative information was presented using percentages (%) or means (M) and standard deviations (SD). The t-test and the chi-squared test were used to compare differences between the vaccine-hesitant/unsure group and the vaccine-acceptance group.
A hierarchical logistic regression analysis was performed to identify the factors that affect the intention to repeat COVID-19 vaccination, comparing nested regression models. We present five models: (1) Model 1: A model with sociodemographic factors; (2) Model 2: COVID-19 infection-related factors are added into the model; (3) Model 3: COVID-19 vaccine-related factors were entered into the model; (4) Model 4: sociocultural factors were entered into the model; and (5) Model 5: communication factors were added into the model. All analyses were performed using R version 4.1.1 (R Foundation for Statistical Computing, Vienna, Austria).

3. Results

3.1. Characteristics of Participants

Of a total of 1000 participants, 50.5% were male and 49.5% were female. The average age of the participants was 46.2 years old (SD = 14.8), and more than three-quarters had received some higher education (76.9%). A total of 60.3% of participants were married, and 28.0% had a monthly household income of 3.00–4.99 million KRW, followed by more than 7.00 million KRW (26.8%), 5.00–6.99 million KRW (24.9%), and less than 3.00 million KRW (20.3%). Approximately half of the participants (53.1%) had been diagnosed with chronic diseases (Table 1).

3.2. Differences in Variables That Affect Intention to Repeat COVID-19 Vaccination

Table 1 presents the results of the t-test and chi-squared test. People who were willing to repeat COVID-19 vaccination (78.9%) outnumbered those who were hesitant/unsure (21.1%). There were some differences in demographic factors between the two groups. Approximately half of the acceptance group (48.3%) was 50 years old and older, while approximately half (48.3%) of the hesitant/unsure group was under 40 years old (p < 0.001). When compared with the hesitant/unsure group, more people in the acceptance group were married (50.2% vs. 63.0%) and had chronic diseases (38.4% vs. 49.2%) (p < 0.01).
There were significant differences between the two groups in COVID-19 infection-related factors, COVID-19 vaccine-related factors, sociocultural factors, and communication factors, except for a history of infection. The accepting group had higher risk perceptions (Mean = 3.14) than the hesitant/unsure group (Mean = 2.91) (p < 0.001). Most participants in the acceptance group have been vaccinated against COVID-19 at least once (97.7%), whereas nearly a quarter (24.6%) of those in the hesitant/unsure group had not been vaccinated (p < 0.001). COVID-19 vaccine adverse events were affiliated with 72.5% of the hesitant/unsure group and 59.1% of the acceptance group (p < 0.001). There were 26.1% of politically conservative people in the hesitant/unsure group and 17.0% in the acceptance group (p < 0.001). The authoritarian attitude was higher in the vaccine acceptance group (Mean = 3.60) than in the hesitant/unsure group (Mean = 3.09) (p < 0.001). More than half of the hesitant/unsure participants (56.4%) considered vaccination as a personal choice, while nearly half of the accepting participants (48.3%) considered vaccination as a social responsibility. Members of the acceptance group had a more favorable attitude toward the regular briefings and lower psychological reactance to the government’s recommendation for vaccination than those in the hesitant/unsure group (p < 0.001).

3.3. Factors Associated with Intention to Repeat COVID-19 Vaccination

Table 2 presents the outcomes of a multivariable hierarchical logistic regression analysis. In Model 1, which includes sociodemographic factors, age was the sole predictor of the intention to repeat COVID-19 vaccination (R2 = 0.028). A one-year increase in age was related to a significant increase in the probability of repeating the COVID-19 vaccination (OR = 1.02, 95% CI = 1.01–1.03). In Model 2, which contained variables related to COVID-19 infection, risk perception was a significant predictor of compliance with repeat COVID-19 vaccinations (OR = 1.63; CI = 1.29–2.06). In Model 3, a model in which COVID-19 vaccine-related factors were included, people who had been vaccinated at least once (OR1–2 = 8.82; CI1–2 = 4.91–16.51) and who had received a booster shot (OR3 = 18.91; CI3 = 10.34–35.98) were more willing to repeat the vaccination compared with unvaccinated people. Those who had vaccine adverse events were less likely to be vaccinated again (OR = 0.48; CI = 0.33–0.69). In Model 4, a model with sociocultural factors, those who had a stronger authoritarian attitude were more likely to repeat COVID-19 vaccinations (OR = 1.60; CI = 1.22–2.10). Compared to those who considered vaccination as a personal decision, those who considered it as a social responsibility (OR = 8.44; CI = 5.00–14.58) and those who considered it as both a personal choice and a social responsibility (OR = 4.23; CI = 2.71–6.66) were more likely to receive an additional vaccine shot. In Model 5, which includes communication factors, those with a positive attitude toward regular briefings were more likely to be vaccinated again (OR = 1.56; CI = 1.20–2.03). People with higher psychological reactance to the government’s vaccination recommendation were less likely to accept repeat COVID-19 vaccinations (OR = 0.74; CI = 0.63–0.86). After controlling for other variables, vaccination status (OR1–2 = 5.13; CI1–2 = 2.61–10.42; OR3 = 6.29; CI3 = 3.10–13.09) and vaccine adverse events (OR = 0.53; CI = 0.34–0.82) were significant predictors of intention to repeat COVID-19 vaccination.

4. Discussion

Immunity gained through vaccination and previous infection, as well as the characteristics of the Omicron variant (the infection rate is faster but less severe than existing viruses), mitigated the severity of COVID-19 and risk perception [13,35,36]. As governments decided to live with and manage the coronavirus, they relaxed or lifted restrictions and vaccination remains the most essential way for health protection [37]. Prior research demonstrated that COVID-19 vaccination, especially for groups at high risk of infection, was more cost-effective than no vaccination [38].
South Korea is regarded as an exemplary case of a COVID-19 vaccination program in the OECD, with a high vaccination rate (87.0%) [9,11]. Despite its successful vaccination program before the Omicron wave, making the public repeat the COVID-19 vaccination is still a challenge. In a study of Canadian adults, for example, acceptance of annual shots was lower than acceptance of a booster shot (third dose), suggesting that vaccine uptake would be dismal if citizens are required to receive COVID-19 vaccination annually [39]. The reported willingness to receive booster shots in other countries varied from 19.3% to 82.4% [39,40,41,42]. In this study, 78.9% of Korean citizens were willing to repeat the COVID-19 vaccination. We explored five factors that influence this intention, and several notable findings could provide insights into vaccine communication for stainable COVID-19 vaccination programs.
First and foremost, most sociodemographic factors, which were the focus of previous studies, were not significant predictors of the intention to repeat the COVID-19 vaccination [22]. Instead, the majority of variables related to COVID-19 infection and vaccination, as well as socio-cultural and communication variables, were associated with the willingness to repeat the COVID-19 vaccination. This indicates that psychological, experiential, and contextual factors, in addition to sociodemographic factors, should be considered to boost the motivation to repeat the vaccination [22,43,44]. In this study, participants who perceived themselves to be more susceptible to contracting a disease or who perceived the severity of infection-related effects were more likely to accept repeated COVID-19 vaccinations, which was consistent with previous studies [19,27]. This can be explained by people’s desire to avoid negative health outcomes and motivation to adopt the action that is expected to reduce the likelihood or severity of harm [45]. It is essential to increase the perceived risk of infection, particularly among those who are physically vulnerable, in order to improve the willingness to repeat immunization [46]. This should be done along with messages about the benefits of vaccination, because loss-framed messages may elicit freedom threats and, consequently, psychological reactance from message recipients [47,48].
People who had a positive attitude toward regular briefing of health authorities were more likely to repeat the vaccination. Open and transparent communication is essential for building trust in health authorities, which impacts trust in vaccination [49,50]. Since the COVID-19 outbreak, the Korea Disease Control and Prevention Agency (KDCA) has regularly provided information about COVID-19, including statistical information (e.g., vaccination rates) and prevention guidelines (e.g., vaccination plans) [51]. Regular briefings have been an essential channel for the public to obtain trustful vaccination information, and vaccine communication may lead to acceptance of repeat vaccination [51,52]. Yet, changes in vaccine communication are needed. In this study, individuals who directly or indirectly experienced adverse events following immunization and who had psychological reactance against the government’s vaccination recommendation were less likely to repeat vaccination. People who had vaccination side effects are more likely to regret their previous vaccination decisions, resulting in decreased intention to get an additional dose [53]. As vague communication concealing undesirable vaccine features (e.g., vaccine side effects) has negative effects in the long run by eroding trust in health authorities, health authorities should keep communication about negative information as well as positive information regarding vaccination [54]. Additionally, messages using freedom-threatening language increase perceived threat and psychological reactance, which in turn decreased perceived message persuasiveness [48,55]. Therefore, health authorities need to be aware of the public’s concerns about vaccination adverse events and communicate with empathy [56]. This can be done, for example, by discussing the difficulties of those affected by vaccine side effects [57].
In the current study, people who received the COVID-19 vaccine at least once were more willing to repeat vaccination. Those who were vaccinated in the past might find vaccination useful and be more willing to accept vaccination in the future [58]. Sharing positive personal experiences with vaccination and reasons for vaccination can influence others’ willingness to vaccinate [59]. In addition, collective responsibility and individual ideology were related to vaccination intention in this study. Those who believed that vaccination is everyone’s responsibility for the health of society and those with an authoritarian attitude were more likely to receive repeat vaccinations. This finding parallels that of a previous study performed in Germany, Poland, and the United Kingdom, which indicated that people who favor obedience to authorities and established norms and who favor punishing the violation of social norms were more likely to receive the COVID-19 vaccine [60]. Therefore, vaccine uptake can be increased by promoting the prosocial aspect of vaccinations by raising people’s knowledge of herd immunity and eliciting empathy and sympathy for those who can benefit from it [61].
We recognize some limitations in our study. As it is a cross-sectional study, it is difficult to infer the causal relationship between dependent and independent variables. In addition, as the intention to repeat COVID-19 vaccination and the related factors may be changed depending on the pandemic context, the relationship between those variables can also change. The results of the current study may not fully reflect Korean citizens’ intention to repeat the COVID-19 vaccination following the survey. Despite these limitations, this study on the intention to repeat the COVID-19 vaccination suggests that psychological, experiential, and sociocultural factors should be considered in vaccination programs and that changes in vaccine communication are needed. These results may provide significant insights into how to deal with COVID-19 and other emerging infectious diseases in the future.

5. Conclusions

In response to the COVID-19 pandemic, vaccination has played a vital role in protecting citizens’ health and lives. The current study identified that COVID-19 infection and vaccine-related factors (risk perception, COVID-19 vaccination status, experience of adverse events), sociocultural factors (authoritarian attitude, collective responsibility), and communication factors (attitude on regular briefing, psychological reactance against vaccination recommendation) affect the intention to repeat the COVID-19 vaccination. The results suggest that effective vaccine communication is necessary for COVID-19 vaccination programs. This includes providing vaccine-related information regularly and transparently, being sensitive to people’s emotions, and encouraging prosocial vaccination.

Author Contributions

Conceptualization, Y.L. and M.Y.; methodology, Y.L. and M.Y.; formal analysis, Y.L.; investigation, Y.L., K.P., J.S. and M.Y.; data curation, Y.L., J.S. and Y.J.; writing—original draft preparation, Y.L.; writing—review and editing, K.P., J.S., J.O. and M.Y.; supervision, K.P. and M.Y.; project administration, Y.J. and J.S. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Gyeonggi Infectious Disease Control Center of the Gyeonggi Provincial Government and the National Research Foundation of Korea (BK21 Center for Integrative Response to Health Disasters, and Graduate School of Public Health, Seoul National University) (NO. 419 999 0514025).

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of Seoul National University (IRB No. 2201/002-008, 6 January 2022).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data used and analyzed in this study are available from the corresponding author upon reasonable request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. WHO (World Health Organization). WHO Coronavirus (COVID-19) Dashboard; WHO: Geneva, Switzerland, 2023.
  2. Perra, N. Non-pharmaceutical interventions during the COVID-19 pandemic: A review. Phys. Rep. 2021, 913, 1–52. [Google Scholar] [CrossRef] [PubMed]
  3. Bok, K.; Sitar, S.; Graham, B.S.; Mascola, J.R. Accelerated COVID-19 vaccine development: Milestones, lessons, and prospects. Immunity 2021, 54, 1636–1651. [Google Scholar] [CrossRef] [PubMed]
  4. Boyon, N. COVID-19 Vaccination Intent Has Risen in the Past Few Weeks. Ipsos 9 February 2021. Available online: https://www.ipsos.com/en/global-attitudes-covid-19-vaccine-january-2021 (accessed on 21 February 2023).
  5. Wang, Y.; Liu, Y. Multilevel determinants of COVID-19 vaccination hesitancy in the United States: A rapid systematic review. Prev. Med. Rep. 2022, 25, 101673. [Google Scholar] [CrossRef]
  6. Song, I.; Lee, S.H. COVID-19 vaccine refusal associated with health literacy: Findings from a population-based survey in Korea. BMC Public Health 2023, 23, 255. [Google Scholar] [CrossRef] [PubMed]
  7. Gaire, A.; Panthee, B.; Basyal, D.; Paudel, A.; Panthee, S. COVID-19 Vaccine Acceptance: A Case Study from Nepal. COVID 2022, 2, 1014–1025. [Google Scholar] [CrossRef]
  8. Mello, M.M.; Opel, D.J.; Benjamin, R.M.; Callaghan, T.; DiResta, R.; Elharake, J.A.; Flowers, L.C.; Galvani, A.P.; Salmon, D.A.; Schwartz, J.L. Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA. Lancet 2022, 400, 535–538. [Google Scholar] [CrossRef]
  9. Kwon, S.L.; Oh, J. COVID-19 vaccination program in South Korea: A long journey toward a new normal. Health Policy Technol. 2022, 11, 100601. [Google Scholar] [CrossRef]
  10. Zheng, C.; Shao, W.; Chen, X.; Zhang, B.; Wang, G.; Zhang, W. Real-world effectiveness of COVID-19 vaccines: A literature review and meta-analysis. Int. J. Infect. Dis. 2022, 114, 252–260. [Google Scholar] [CrossRef]
  11. Mathieu, E.; Ritchie, H.; Rodés-Guirao, L.; Appel, C.; Giattino, C.; Hasell, J.; Macdonald, B.; Dattani, S.; Beltekian, D.; Ortiz-Ospina, E.; et al. Coronavirus Pandemic (COVID-19). Our World in Data 2020. Available online: https://ourworldindata.org/coronavirus (accessed on 21 February 2023).
  12. Iuliano, A.D.; Brunkard, J.M.; Boehmer, T.K.; Peterson, E.; Adjei, S.; Binder, A.M.; Cobb, S.; Graff, P.; Hidalgo, P.; Panaggio, M.J. Trends in disease severity and health care utilization during the early Omicron variant period compared with previous SARS-CoV-2 high transmission periods—United States, December 2020–January 2022. Morb. Mortal. Wkly. Rep. 2022, 71, 146–152. [Google Scholar] [CrossRef]
  13. Bobrovitz, N.; Ware, H.; Ma, X.; Li, Z.; Hosseini, R.; Cao, C.; Selemon, A.; Whelan, M.; Premji, Z.; Issa, H.; et al. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: A systematic review and meta-regression. Lancet Infect. Dis. 2023, 23, 556–567. [Google Scholar] [CrossRef]
  14. Ellyatt, H. Back to Reality at Last? Covid Rules Are Being Dropped in Europe Despite High Omicron Spread. CNBC, 27 January 2022. Available online: https://www.cnbc.com/2022/01/27/covid-rules-are-being-dropped-in-europe-despite-high-omicron-spread.html (accessed on 21 February 2023).
  15. Marks, P.; Woodcock, J.; Califf, R. COVID-19 vaccination—Becoming part of the new normal. JAMA 2022, 327, 1863–1864. [Google Scholar] [CrossRef] [PubMed]
  16. Lazarus, J.V.; Wyka, K.; White, T.M.; Picchio, C.A.; Gostin, L.O.; Larson, H.J.; Rabin, K.; Ratzan, S.C.; Kamarulzaman, A.; El-Mohandes, A. A survey of COVID-19 vaccine acceptance across 23 countries in 2022. Nat. Med. 2023, 29, 366–375. [Google Scholar] [CrossRef] [PubMed]
  17. Dubé, E.; MacDonald, N.E. Vaccine acceptance: Barriers, perceived risks, benefits, and irrational beliefs. In The Vaccine Book; Bloom, B.R., Lambert, P.H., Eds.; Academic Press: London, UK, 2016; pp. 507–528. [Google Scholar]
  18. Goodwin, R.; Ben-Ezra, M.; Takahashi, M.; Luu, L.A.N.; Borsfay, K.; Kovács, M.; Hou, W.K.; Hamama-Raz, Y.; Levin, Y. Psychological factors underpinning vaccine willingness in Israel, Japan and Hungary. Sci. Rep. 2022, 12, 439. [Google Scholar] [CrossRef] [PubMed]
  19. Joshi, A.; Kaur, M.; Kaur, R.; Grover, A.; Nash, D.; El-Mohandes, A. Predictors of COVID-19 Vaccine Acceptance, Intention, and Hesitancy: A Scoping Review. Front. Public Health 2021, 9, 698111. [Google Scholar] [CrossRef] [PubMed]
  20. Campos-Matos, I.; Mandal, S. Annex A: COVID-19 Vaccine and Health Inequalities: Considerations for Prioritisation and Implementation; Department of Health and Social Care: London, UK, 2021.
  21. Jennings, W.; Stoker, G.; Bunting, H.; Valgarðsson, V.O.; Gaskell, J.; Devine, D.; McKay, L.; Mills, M.C. Lack of Trust, Conspiracy Beliefs, and Social Media Use Predict COVID-19 Vaccine Hesitancy. Vaccines 2021, 9, 593. [Google Scholar] [CrossRef]
  22. Galanis, P.; Vraka, I.; Katsiroumpa, A.; Siskou, O.; Konstantakopoulou, O.; Katsoulas, T.; Mariolis-Sapsakos, T.; Kaitelidou, D. First COVID-19 Booster Dose in the General Population: A Systematic Review and Meta-Analysis of Willingness and Its Predictors. Vaccines 2022, 10, 1097. [Google Scholar] [CrossRef]
  23. Kim, I.H.; Park, A.K.; Lee, H.; Kim, H.M.; Kim, J.; Kim, J.A.; No, J.S.; Lee, C.; Rhee, J.E.; Kim, E.J. Status and characteristics of the SARS-CoV-2 variant outbreak in the Republic of Korea in January 2021. Public Health Wkly. Rep. 2022, 15, 505–510. [Google Scholar] [CrossRef]
  24. KDCA (Korea Disease Control and Prevention Agency). COVID-19 Booster Shot Guideline for Foreign Nationals Staying in the Republic of Korea; KDCA: Cheongju, Republic of Korea, 2022. Available online: https://ncv.kdca.go.kr/board.es?mid=a12105000000&bid=0035&act=view&list_no=673 (accessed on 21 February 2023).
  25. CDC (Centers for Disease Control and Prevention). Estimates of Vaccine Hesitancy for COVID-19; CDC: Atlanta, GA, USA, 2021.
  26. KDCA. Korea National Health and Nutrition Examination Survey (KNHANES) VIII; KDCA: Cheongju, Republic of Korea, 2021.
  27. Brewer, N.T.; Chapman, G.B.; Gibbons, F.X.; Gerrard, M.; McCaul, K.D.; Weinstein, N.D. Meta-analysis of the relationship between risk perception and health behavior: The example of vaccination. Health Psychol. 2007, 26, 136–145. [Google Scholar] [CrossRef]
  28. Ju, Y.; You, M. It’s Politics, Isn’t It? Investigating Direct and Indirect Influences of Political Orientation on Risk Perception of COVID-19. Risk Anal. 2022, 42, 56–68. [Google Scholar] [CrossRef]
  29. Duckitt, J. Authoritarianism and group identification: A new view of an old construct. Political Psychol. 1989, 10, 63–84. [Google Scholar] [CrossRef]
  30. Douglas, M.; Wildavsky, A. Risk and Culture: An Essay on the Selection of Technological and Environmental Dangers; University of California Press: Berkeley, CA, USA, 1983. [Google Scholar]
  31. Marris, C.; Langford, I.H.; O’Riordan, T. A quantitative test of the cultural theory of risk perceptions: Comparison with the psychometric paradigm. Risk Anal. 1998, 18, 635–647. [Google Scholar] [CrossRef] [PubMed]
  32. Hamel, L.; Kirzinger, A.; Muñana, C.; Brodie, M. KFF COVID-19 Vaccine Monitor: December 2020; Kaiser Family Foundation: San Francisco, CA, USA, 2020. [Google Scholar]
  33. CDCH (Central Disease Control Headquarters). Status of the COVID-19 Outbreak in South Korea (Regular Briefing on 5 May); KDCA: Cheongju, Republic of Korea, 2020. Available online: http://www.mohw.go.kr/react/al/sal0301vw.jsp?PAR_MENU_ID=04&MENU_ID=0403&CONT_SEQ=354363&page=1 (accessed on 21 February 2023).
  34. Sprengholz, P.; Betsch, C.; Böhm, R. Reactance revisited: Consequences of mandatory and scarce vaccination in the case of COVID-19. Appl. Psychol. Health Well Being 2021, 13, 986–995. [Google Scholar] [CrossRef] [PubMed]
  35. Hui, K.P.Y.; Ho, J.C.W.; Cheung, M.-C.; Ng, K.-C.; Ching, R.H.H.; Lai, K.-l.; Kam, T.T.; Gu, H.; Sit, K.-Y.; Hsin, M.K.Y.; et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature 2022, 603, 715–720. [Google Scholar] [CrossRef] [PubMed]
  36. Jackson, C.; Newall, M.; Duran, J.; Rollason, C.; Golden, J. Most Americans Not Worrying about COVID Going into 2022 Holidays. Ipsos 6 December 2022. Available online: https://www.ipsos.com/en-us/news-polls/axios-ipsos-coronavirus-index (accessed on 21 February 2023).
  37. The Cabinet Office. COVID-19 Response: Living with COVID-19; The Cabinet Office: London, UK, 2022.
  38. Zhou, L.; Yan, W.; Li, S.; Yang, H.; Zhang, X.; Lu, W.; Liu, J.; Wang, Y. Cost-effectiveness of interventions for the prevention and control of COVID-19: Systematic review of 85 modelling studies. J. Glob. Health 2022, 12, 05022. [Google Scholar] [CrossRef] [PubMed]
  39. Reifferscheid, L.; Lee, J.S.W.; MacDonald, N.E.; Sadarangani, M.; Assi, A.; Lemaire-Paquette, S.; MacDonald, S.E. Transition to endemic: Acceptance of additional COVID-19 vaccine doses among Canadian adults in a national cross-sectional survey. BMC Public Health 2022, 22, 1745. [Google Scholar] [CrossRef]
  40. Williams, L.; Gallant, A.; Brown, L.; Corrigan, K.; Crowe, K.; Hendry, E. Barriers and facilitators to the future uptake of regular COVID-19 booster vaccinations among young adults in the UK. Hum. Vaccines Immunother. 2022, 18, 2129238. [Google Scholar] [CrossRef]
  41. Weitzer, J.; Birmann, B.M.; Steffelbauer, I.; Bertau, M.; Zenk, L.; Caniglia, G.; Laubichler, M.D.; Steiner, G.; Schernhammer, E.S. Willingness to receive an annual COVID-19 booster vaccine in the German-speaking D-A-CH region in Europe: A cross-sectional study. Lancet Reg. Health Eur. 2022, 18, 100414. [Google Scholar] [CrossRef] [PubMed]
  42. Abuhammad, S.; Khabour, O.F.; Alzoubi, K.H.; Hamaideh, S.; Alzoubi, B.A.; Telfah, W.S.; El-zubi, F.K. The public’s attitude to and acceptance of periodic doses of the COVID-19 vaccine: A survey from Jordan. PLoS ONE 2022, 17, e0271625. [Google Scholar] [CrossRef]
  43. WHO. Appendices to the Report of the SAGE Working Group on Vaccine Hesitancy; WHO: Geneva, Switzerland, 2014.
  44. Schmid, P.; Rauber, D.; Betsch, C.; Lidolt, G.; Denker, M.L. Barriers of influenza vaccination intention and behavior–A systematic review of influenza vaccine hesitancy, 2005–2016. PLoS ONE 2017, 12, e0170550. [Google Scholar] [CrossRef]
  45. Weinstein, N.D. Testing four competing theories of health-protective behavior. Health Psychol. 1993, 12, 324–333. [Google Scholar] [CrossRef]
  46. Qin, C.; Yan, W.; Tao, L.; Liu, M.; Liu, J. The Association between Risk Perception and Hesitancy toward the Booster Dose of COVID-19 Vaccine among People Aged 60 Years and Older in China. Vaccines 2022, 10, 1112. [Google Scholar] [CrossRef] [PubMed]
  47. Shmueli, L. Predicting intention to receive COVID-19 vaccine among the general population using the health belief model and the theory of planned behavior model. BMC Public Health 2021, 21, 804. [Google Scholar] [CrossRef]
  48. Reynolds-Tylus, T. Psychological reactance and persuasive health communication: A review of the literature. Front. Commun. 2019, 4, 56. [Google Scholar] [CrossRef]
  49. WHO. COVID-19 Vaccines: Safety Surveillance Manual; WHO: Geneva, Switzerland, 2020.
  50. OECD (Organization for Economic Cooperation and Development). Enhancing Public Trust in COVID-19 Vaccination: The Role of Governments; OECD Publishing: Paris, France, 2021. [Google Scholar]
  51. KDCA. The KDCA’s COVID-19 Risk Communication; KDCA: Cheongju, Republic of Korea, 2022.
  52. CDMH (Central Disaster Management Headquarters). Results of a Survey on COVID-19 Perception (July); MOHW (Ministry of Health and Welfare): Sejong, Republic of Korea, 2021. Available online: http://www.mohw.go.kr/react/al/sal0301vw.jsp?PAR_MENU_ID=04&MENU_ID=0403&BOARD_ID=140&BOARD_FLAG=00&CONT_SEQ=366709 (accessed on 21 February 2023).
  53. Luo, C.; Chen, H.X.; Tung, T.H. COVID-19 vaccination in China: Adverse effects and its impact on health care working decisions on booster dose. Vaccines 2022, 10, 1229. [Google Scholar] [CrossRef]
  54. Petersen, M.B.; Bor, A.; Jørgensen, F.; Lindholt, M.F. Transparent communication about negative features of COVID-19 vaccines decreases acceptance but increases trust. Proc. Natl. Acad. Sci. USA 2021, 118, e2024597118. [Google Scholar] [CrossRef] [PubMed]
  55. Quick, B.L.; Considine, J.R. Examining the use of forceful language when designing exercise persuasive messages for adults: A test of conceptualizing reactance arousal as a two-step process. Health Commun. 2008, 23, 483–491. [Google Scholar] [CrossRef] [PubMed]
  56. Pan American Health Organization. Communicating about Vaccine Safety: Guidelines to Help Health Workers Communicate with Parents, Caregivers, and Patients; Pan American Health Organization: Washington, DC, USA, 2020.
  57. Hyland-Wood, B.; Gardner, J.; Leask, J.; Ecker, U.K.H. Toward effective government communication strategies in the era of COVID-19. Humanit Soc. Sci. Commun. 2021, 8, 30. [Google Scholar] [CrossRef]
  58. Zhu, W.; Zou, H.; Song, Y.; Ren, L.; Xu, Y. Understanding the continuous vaccination of the COVID-19 vaccine: An empirical study from China. Hum. Vaccines Immunother. 2021, 17, 4954–4963. [Google Scholar] [CrossRef]
  59. Ung, C.O.L.; Hu, Y.; Hu, H.; Bian, Y. Investigating the intention to receive the COVID-19 vaccination in Macao: Implications for vaccination strategies. BMC Infect. Dis. 2022, 22, 218. [Google Scholar] [CrossRef]
  60. Bilewicz, M.; Soral, W. The politics of vaccine hesitancy: An ideological dual-process approach. Soc. Psychol. Pers. Sci. 2021, 13, 1080–1089. [Google Scholar] [CrossRef]
  61. Böhm, R.; Betsch, C. Prosocial vaccination. Curr. Opin. Psychol. 2022, 43, 307–311. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Conceptual framework of vaccination-related factors (adapted with permission from Ref. [19]. 2021, Joshi, Kaur, Kaur, Grover, Nash, and El-Mohandes).
Figure 1. Conceptual framework of vaccination-related factors (adapted with permission from Ref. [19]. 2021, Joshi, Kaur, Kaur, Grover, Nash, and El-Mohandes).
Healthcare 11 01235 g001
Table 1. Characteristics of participants by intention to repeat COVID-19 vaccination.
Table 1. Characteristics of participants by intention to repeat COVID-19 vaccination.
Intention to Repeat COVID-19 Vaccination
All SubjectsHesitant/UnsureAcceptancet-Test/Χ2
N%N%N%p-Value
1000100.0211100789100
Sex 0.750
Male50550.510449.340150.8
Female49549.510750.738849.2
Age (M(SD))46.2 (14.8)42.1 (15.4)47.3 (14.4)<0.001 ***
18–29 years18218.25827.512415.7
30–39 years16516.54420.812115.3
40–49 years19919.93617.116320.7
50–59 years20120.13014.217121.7
≥60 years25325.34320.421026.6
Education 0.290
Less than High school23123.15526.117622.3
College and above76976.915673.961377.7
Marital Status 0.001 **
Single/Divorced/Widowed39739.710549.829237.0
Married60360.310650.249763.0
Monthly Household Income 0.214
<3.0020320.34923.215419.5
3.00–4.9928028.04822.823229.4
5.00–6.9924924.95827.519124.2
≥7.0026826.85626.521226.9
Health status (Chronic Disease) 0.007 **
No53153.113061.640150.8
Yes46946.98138.438849.2
Risk Perception (M(SD))3.09 (0.64)2.91 (0.74)3.14 (0.60)<0.001 ***
History of Infection 0.935
No69269.214769.754569.1
Yes30830.86430.324430.9
Vaccination Status <0.001 ***
0707.05224.6182.3
1–240240.27046.030538.7
3 (booster shot)5252.86229.446659.0
Vaccine adverse events <0.001 ***
No38138.15827.532340.9
Yes61961.915372.546659.1
Political ideology <0.001 ***
Conservative18918.95526.113417.0
Moderate58458.412257.846258.5
Liberal19019.02310.916721.2
Don’t know373.7115.2263.3
Authoritarian attitude (M (SD))3.49 (0.73)3.09 (0.82)3.60 (0.66)<0.001 ***
Collective responsibility <0.001 ***
Personal Choice21321.311956.49411.9
Everyone’s responsibility40840.82712.838148.3
Both34934.95325.129637.5
Neither90.952.440.5
Don’t know212.173.3141.8
Attitude on regular briefing (M (SD))3.22 (0.89)2.58 (0.91)3.39 (0.80)<0.001 ***
Psychological reactance against the government’s vaccination recommendation (M (SD))4.71 (1.58)5.79 (1.44)4.42 (1.49)<0.001 ***
Notes. * p < 0.050, ** p < 0.010, *** p < 0.001. million KRW (KRW 1 = USD 0.00076).
Table 2. Hierarchical logistic regression analysis of intention to repeat COVID-19 vaccination.
Table 2. Hierarchical logistic regression analysis of intention to repeat COVID-19 vaccination.
PredictorsModel 1Model 2Model 3Model 4Model 5
OR (95% CI)OR (95% CI)OR (95% CI)OR (95% CI)OR (95% CI)
Sex
MaleRefRefRefRefRef
Female0.94 (0.69–1.28)0.87 (0.63–1.20)1.03 (0.73–1.45)0.91 (0.62–1.34)0.89 (0.60–1.31)
Age1.02 (1.01–1.03) **1.02 (1.01–1.03) **1.00 (0.99–1.02)1.00 (0.98–1.01)1.00 (0.98–1.01)
Education
Less than High schoolRefRefRefRefRef
College and above1.43 (0.99–2.06)1.42 (0.98–2.06)1.29 (0.85–1.93)1.28 (0.80–2.02)1.32 (0.82–2.11)
Marital Status
Single/Divorced/WidowedRefRefRefRefRef
Married1.22 (0.83–1.78)1.18 (0.80–1.74)1.44 (0.95–2.18)1.5 (0.95–2.38)1.6 (0.99–2.56)
Monthly Household Income1.00 (0.94–1.07)1.00 (0.94–1.07)0.99 (0.92–1.07)0.98 (0.90–1.06)0.98 (0.90–1.06)
Health status (Chronic Disease)
NoRefRefRefRefRef
Yes1.29 (0.93–1.81)1.24 (0.88–1.73)1.37 (0.95–1.99)1.37 (0.91–2.08)1.41 (0.92–2.17)
Risk perception 1.63 (1.29–2.06) ***1.61 (1.24–2.09) ***1.33 (1.01–1.77) *1.28 (0.95–1.71)
History of Infection
No RefRefRefRef
Yes 1.00 (0.72–1.42)1.05 (0.73–1.52)1.04 (0.70–1.56)1.11 (0.73–1.69)
Vaccination status
0 RefRefRef
1–2 8.82 (4.91–16.51) ***5.51 (2.85–11.01) ***5.13 (2.61–10.42) ***
3 18.91 (10.34–35.98) ***7.35 (3.69–15.04) ***6.29 (3.10–13.09) ***
Vaccine adverse events
No RefRefRef
Yes 0.48 (0.33–0.69) ***0.51 (0.33–0.77) **0.53 (0.34–0.82) **
Political ideology
Conservative RefRef
Moderate 1.44 (0.89–2.30)1.27 (0.78–2.06)
Liberal 1.76 (0.92–3.43)1.17 (0.59–2.36)
Don’t know 0.77 (0.31–1.97)0.63 (0.25–1.68)
Authoritarian attitude 1.60 (1.22–2.10) **1.22 (0.91–1.65)
Collective responsibility
Personal choice RefRef
Everyone’s responsibility 8.44 (5.00–14.58) ***4.83 (2.75–8.61) ***
Both 4.23 (2.71–6.66) ***3.08 (1.92–4.96) ***
Neither 1.30 (0.25–6.66)1.18 (0.23–5.91)
Don’t know 1.71 (0.63–5.01)1.40 (0.50–4.16)
Attitude on regular briefing 1.56 (1.20–2.03) **
Psychological reactance against the government’s vaccination recommendation 0.74 (0.63–0.86) ***
R2 Tjur0.0280.0470.1860.3110.346
ΔR2 0.019 ***0.139 ***0.125 ***0.035 ***
Note. * p < 0.050, ** p < 0.010, *** p < 0.001.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Lee, Y.; Park, K.; Shin, J.; Oh, J.; Jang, Y.; You, M. Factors Affecting the Public Intention to Repeat the COVID-19 Vaccination: Implications for Vaccine Communication. Healthcare 2023, 11, 1235. https://doi.org/10.3390/healthcare11091235

AMA Style

Lee Y, Park K, Shin J, Oh J, Jang Y, You M. Factors Affecting the Public Intention to Repeat the COVID-19 Vaccination: Implications for Vaccine Communication. Healthcare. 2023; 11(9):1235. https://doi.org/10.3390/healthcare11091235

Chicago/Turabian Style

Lee, Yubin, Kunhee Park, Jeonghoon Shin, Jeonghyeon Oh, Yeongeun Jang, and Myoungsoon You. 2023. "Factors Affecting the Public Intention to Repeat the COVID-19 Vaccination: Implications for Vaccine Communication" Healthcare 11, no. 9: 1235. https://doi.org/10.3390/healthcare11091235

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop